- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
RotoGro Claims Patent Infringement Against RavenQuest
RotoGro claims its Canadian patent for a gardening system is being infringed upon by RavenQuest and its CEO George Robinson.
RotoGro International (ASX:RGI) is claiming patent infringement by Canadian cannabis company RavenQuest BioMed (CSE:RQB).
On Monday (November 4), RotoGro — a subsidiary of RotoGro International — indicated that it has filed a claim in the Federal Court of Canada against RavenQuest due to patent infringement.
Court documents show the claim was filed at the end of October. According to the filed documents, RotoGro also names CL2G Consulting, Synergy Solutions Management, 1052543 BC and William George Robinson, who acts as CEO of RavenQuest.
The Australian company obtained its patent in October from the Canadian Intellectual Property Office. The patent grants RotoGro exclusive rights to its gardening system.
This dispute goes back to the end of 2017. According to RotoGro, Robinson purchased two RotoGro patented gardening systems under the CL2G name in July 2017. Later in the year, the executive attempted to negotiate a licencing deal for the intellectual property rights to the system.
RotoGro argues that despite there never being a formal licencing agreement between the two parties, or with RavenQuest, a promotional paper for the Canadian firm includes what the company describes as an unlicenced drawing identical to the one for its patent.
Adam Clode, CEO of RotoGro, said the acquired patents for the company’s gardening system in the US and Canada are vital to its business in North America and that RotoGro will defend its claim.
“As such, it is important for us to protect and defend our inventions against all individuals and businesses that look to replicate and unlawfully benefit from our patented and proprietary intellectual property,” said Clode. “We owe this duty to our shareholders, and to the company as a whole.”
According to RotoGro, the patent itself protects the following: “A stacked rotatable gardening system comprising numerous modular rotatable gardens being stacked vertically (i.e., one on top of the other) and horizontally (i.e., side by side), where each main frame is connected to the main frame of the other modular rotatable garden, forming system pods.”
On Wednesday (November 6), RavenQuest issued its own response to the claim from the Australian firm. The Canadian company indicated that the notice from RotoGro has no merit since the system RavenQuest uses was developed with its own intellectual property.
“The board of directors of Ravenquest has commenced a review of the claim, and has engaged counsel to defend its intellectual property rights and ensure that its business interests are fully protected,” the company stated.
Shares of RotoGro have been on the rise since it made its claim public to the market on Monday. However, in Wednesday’s trading session, the company fell 5.56 percent to a closing price of AU$0.17.
RavenQuest has seen a steady share price drop since Monday; on Wednesday the company opened at a price of C$0.14 and faced a slash of 9.38 percent in value. Since Monday, shares of the company have dropped 34.1 percent.
Don’t forget to follow us @INN_Australia for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
2024 Life Science Outlook Report
Get the trends and expert predictions you need to stay ahead of the markets.
Download your outlook report today.
Learn About Exciting Investing Opportunities in the Life Science Sector
Your Newsletter Preferences
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.